SLC6A3 and Parkinson disease: Moreover, it has been reported that blockers of dopamine transporter, such as methylphenidate and modafinil, also reduce fatigue scores supporting the involvement of dopaminergic neurotransmission dysfunction in the aetiopathology of fatigue in Parkinson’s disease.8